000043401 001__ 43401
000043401 005__ 20240617125020.0
000043401 0247_ $$2doi$$a10.6083/bpxhc43401
000043401 037__ $$aETD
000043401 041__ $$aeng
000043401 245__ $$aStudying the efficacy of Nirmatrelvir and Ritonavir (Paxlovid) for outpatient treatment of COVID-19 in the pediatric population using real-world data from the National COVID Cohort Collaborative (N3C)
000043401 260__ $$bOregon Health and Science University
000043401 269__ $$a2024-06-16
000043401 336__ $$aCapstone
000043401 502__ $$bM.S.
000043401 502__ $$gHealth & Clinical Informatics
000043401 520__ $$aThis study analyzes the efficacy of Nirmatrelvir and Ritonavir (NMV-r; Paxlovid) for outpatient treatment of COVID-19 in the pediatric population in the age group 12-18 years by using real-world data from N3C. The study uses propensity matching to create a treatment cohort and a control cohort. It further analyzes the clinical outcome such as hospitalization and ED visits following infection with COVID-19.
000043401 540__ $$fCC BY
000043401 542__ $$fIn copyright - single owner
000043401 650__ $$aCOVID-19$$013515
000043401 650__ $$aRitonavir$$031621
000043401 6531_ $$apropensity matching 
000043401 6531_ $$anirmatrelvir
000043401 6531_ $$apaxlovid
000043401 691__ $$aSchool of Medicine$$041369
000043401 692__ $$aDepartment of Medical Informatics and Clinical Epidemiology$$041422
000043401 7001_ $$aKumar, Manish$$uOregon Health and Science University$$041354$$10009-0002-4378-8136
000043401 7201_ $$aWalker, Lorne$$uOregon Health and Science University$$041354$$10000-0002-2500-0504$$eAdvisor$$7Personal
000043401 8564_ $$90a531062-26b5-4afe-9fe1-d8996fad4631$$s300766$$uhttps://digitalcollections.ohsu.edu/record/43401/files/kumar.manish.2024.pdf
000043401 909CO $$ooai:digitalcollections.ohsu.edu:43401$$pstudent-work
000043401 980__ $$aTheses and Dissertations
000043401 981__ $$aPublished$$b2024-06-17